Intec Pharma Ltd. (NTEC) relating to its proposed merger with Decoy Biosystems. Under the terms of the agreement, NTEC shareholders will own 25% of the combined company.
Intec Pharma Ltd. (NTEC) relating to its proposed merger with Decoy Biosystems. Under the terms of the agreement, NTEC shareholders will own 25% of the combined company.